Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor.
Leflunomide in renal transplantation.
Optimizing thiophosphorylation in the presence of competing phosphorylation with MALDI-TOF-MS detection.
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
Systolic blood pressure and cardiovascular outcomes during treatment of hypertension. Am J Med. 2013 Jun; 126(6):501-8.
View in:
PubMed
subject areas
Aged
Antihypertensive Agents
Cardiovascular Diseases
Double-Blind Method
Drug Therapy, Combination
Endpoint Determination
Female
Humans
Hypertension
Male
Proportional Hazards Models
Risk Factors
Systole
Treatment Outcome